Kun at den overdødelighed der var i dara-armen (2 pts) ikke skyldtes dara men sygdomsprogression. En forklaring på manglende effekt har vi ikke set - så vidt jeg ved.
Jan said once that if Janssen continued in solid tumours it will be with sc dosing and first after approval i MM - no need to jeopadize with unpleasent deaths in a solid tumour trial
Interesting purpose by the way: to determine whether premedication with corticosteroids is required to improve the tolerability of SC administration of daratumumab in healthy participants.
det er også mine tanker. Jeg har ikke hørt om dara sc programmer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
